Skip to main content

Table 2 Patient characteristics

From: MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index

 

IDRC

LLMPP R-CHOP

AAU

n

468

233

73

Gender

 Female

198 (42%)

99 (42%)

30 (41%)

 Male

270 (58%)

134 (58%)

43 (59%)

Age

 Median

63

61

66

 Range

18–92

17–92

20–87

IPI

 0–1

254 (54%)

94 (40%)

48 (66%)

 2–5

168 (36%)

70 (30%)

21 (29%)

 NA

46 (10%)

69 (30%)

4 (5%)

ABC / GCB

 ABC

199 (43%)

93 (40%)

32 (44%)

 GCB

225 (48%)

107 (46%)

32 (44%)

 UC

44 (9%)

33 (14%)

9 (12%)

  1. Number of patients and percentage within cohort / variable. ABC activated B-cell-like, GCB germinal center B-cell-like, IPI International prognostic index, NA not available, n number of patients, UC unclassified
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us